BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26951488)

  • 1. Presenting features and platelet anomalies in WAS: one centre's experience.
    Tsilifis C; Gennery AR; Cant A
    J Clin Immunol; 2016 May; 36(4):354-6. PubMed ID: 26951488
    [No Abstract]   [Full Text] [Related]  

  • 2. A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size.
    Patel PD; Samanich JM; Mitchell WB; Manwani D
    Pediatr Blood Cancer; 2011 Jul; 56(7):1127-9. PubMed ID: 21488158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ultrastructure of the blood platelets in Wiskott-Aldrich syndrome].
    Trung PH; Griscelli C; Mozziconacci P
    Pathol Biol (Paris); 1975 Jan; 23(1):57-62. PubMed ID: 1105327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features and Outcomes of 23 Patients with Wiskott-Aldrich Syndrome: A Single-Center Experience.
    Haskoloğlu Ş; Öztürk A; Öztürk G; Kostel Bal S; İslamoğlu C; Baskın K; Ceylaner S; Tufan Satıroğlu L; Doğu F; İkincioğulları A
    Turk J Haematol; 2020 Nov; 37(4):271-281. PubMed ID: 32812413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Persistent thrombocytopenia in a child: morphological examination of blood platelets established the diagnosis of Wiskott-Aldrich syndrome].
    Latger-Cannard V; Lacroix F; Devignes J; Salignac S; Bensoussan D; Salmon A; Mansuy L; Bordigoni P; Lecompte T
    Ann Biol Clin (Paris); 2008; 66(1):100-4. PubMed ID: 18227012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and emerging treatment options for Wiskott-Aldrich syndrome.
    Worth AJ; Thrasher AJ
    Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Wiskott-Aldrich syndrome].
    Gulácsy V; Maródi L
    Orv Hetil; 2008 Jul; 149(29):1367-71. PubMed ID: 18617469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Complex-Mediated Glomerulonephritis in a Patient with Wiskott-Aldrich Syndrome.
    Shigemura T; Nakazawa Y; Shimojo H; Kobayashi N; Agematsu K
    J Clin Immunol; 2016 May; 36(4):357-9. PubMed ID: 26961359
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of severe thrombocytopenia with IL-11 in children with Wiskott-Aldrich syndrome.
    Braithwaite K; Abu-Ghosh A; Anderson L; Cairo MS
    J Pediatr Hematol Oncol; 2002 May; 24(4):323-6. PubMed ID: 11972106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
    Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
    Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wiskott-Aldrich syndrome: molecular pieces slide into place.
    Kuska B
    J Natl Cancer Inst; 2000 Jan; 92(1):9-11. PubMed ID: 10620622
    [No Abstract]   [Full Text] [Related]  

  • 12. Wiskott Aldrich syndrome presenting as congenital thrombocytopenia.
    Lawson SE; Thompson L; Williams MD
    Clin Lab Haematol; 1999 Dec; 21(6):397-9. PubMed ID: 10671992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Wiskott-Aldrich syndrome].
    Belohradsky BH; Griscelli C; Fundenberg HH; Marget W
    Ergeb Inn Med Kinderheilkd; 1978; 41():85-184. PubMed ID: 361383
    [No Abstract]   [Full Text] [Related]  

  • 14. Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features.
    Ariga T
    Allergol Int; 2012 Jun; 61(2):183-9. PubMed ID: 22361515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wiskott-Aldrich syndrome is an important differential diagnosis in male infants with juvenile myelomonocytic leukemialike features.
    Watanabe N; Yoshimi A; Kamachi Y; Kawabe T; Muramatsu H; Matsumoto K; Manabe A; Kojima S; Kato K
    J Pediatr Hematol Oncol; 2007 Dec; 29(12):836-8. PubMed ID: 18090932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukaemia.
    Yoshimi A; Kamachi Y; Imai K; Watanabe N; Nakadate H; Kanazawa T; Ozono S; Kobayashi R; Yoshida M; Kobayashi C; Hama A; Muramatsu H; Sasahara Y; Jakob M; Morio T; Ehl S; Manabe A; Niemeyer C; Kojima S
    Pediatr Blood Cancer; 2013 May; 60(5):836-41. PubMed ID: 23023736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile and genetic basis of Wiskott-Aldrich syndrome at Chandigarh, North India.
    Suri D; Singh S; Rawat A; Gupta A; Kamae C; Honma K; Nakagawa N; Imai K; Nonoyama S; Oshima K; Mitsuiki N; Ohara O; Bilhou-Nabera C; Proust A; Ahluwalia J; Dogra S; Saikia B; Minz RW; Sehgal S
    Asian Pac J Allergy Immunol; 2012 Mar; 30(1):71-8. PubMed ID: 22523910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations in patients with Wiskott-Aldrich syndrome submitted to haematopoietic stem cell transplantation.
    Loyola Presa JG; de Carvalho VO; Morrisey LR; Bonfim CM; Abagge KT; Vasselai A; Marinoni LP
    Arch Dis Child; 2013 Apr; 98(4):304-7. PubMed ID: 23343520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wiskott-Aldrich Syndrome Misdiagnosed as Immune Thrombocytopenic Purpura: A Case Report.
    Karalexi MA; Tzanoudaki M; Fryganas A; Gkergki A; Spyropoulou D; Papadopoulou A; Papaevangelou V; Petrocheilos I
    J Pediatr Hematol Oncol; 2018 Apr; 40(3):240-242. PubMed ID: 28859046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene.
    Oshima K; Imai K; Albert MH; Bittner TC; Strauss G; Filipovich AH; Morio T; Kapoor N; Dalal J; Schultz KR; Casper JT; Notarangelo LD; Ochs HD; Nonoyama S
    J Clin Immunol; 2015 Jan; 35(1):15-21. PubMed ID: 25388447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.